Click for best price
Cancer Molecular Biomarkers Market Size, Share 2022
Cancer molecular biomarkers refer to naturally-occurring molecules or genes in living organisms, which is an indicator for the presence of cancer in the body.A biomarker is a measurable indicator of biological process, condition, or disease and can be found in the blood, tissues, or other body fluids. Cancer molecular biomarkers help to diagnose cancer and monitor patients? responses to treatments.
This report contains market size and forecasts of Cancer Molecular Biomarkers in Global, including the following market information:
Global Cancer Molecular Biomarkers Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Cancer Molecular Biomarkers market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Genetic Methods Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Cancer Molecular Biomarkers include Correlogic Systems, AgendiaBv, BioMerieux, Aureon Laboratories, Astellas Pharma US, Becton, Diadexus, Abbott Laboratories and Affymetrix, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Cancer Molecular Biomarkers companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Cancer Molecular Biomarkers Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Cancer Molecular Biomarkers Market Segment Percentages, by Type, 2021 (%)
Genetic Methods
Protein Methods
Imaging
Global Cancer Molecular Biomarkers Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Cancer Molecular Biomarkers Market Segment Percentages, by Application, 2021 (%)
Pharmaceutical
Medical Laboratory
Hospital
Global Cancer Molecular Biomarkers Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Cancer Molecular Biomarkers Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Cancer Molecular Biomarkers revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Cancer Molecular Biomarkers revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Correlogic Systems
AgendiaBv
BioMerieux
Aureon Laboratories
Astellas Pharma US
Becton
Diadexus
Abbott Laboratories
Affymetrix
Clarient
Biomoda
Beckman Coulter
Dickinson
| Report Attributes |
Report Details |
| Report Title |
Cancer Molecular Biomarkers Market - Global Outlook and Forecast 2022-2028 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2021 |
| Forecast Year |
2029 |
| Number of Pages |
65 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Cancer Molecular Biomarkers Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Cancer Molecular Biomarkers Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Cancer Molecular Biomarkers Overall Market Size
2.1 Global Cancer Molecular Biomarkers Market Size: 2021 VS 2028
2.2 Global Cancer Molecular Biomarkers Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Cancer Molecular Biomarkers Players in Global Market
3.2 Top Global Cancer Molecular Biomarkers Companies Ranked by Revenue
3.3 Global Cancer Molecular Biomarkers Revenue by Companies
3.4 Top 3 and Top 5 Cancer Molecular Biomarkers Companies in Global Market, by Revenue in 2021
3.5 Global Companies Cancer Molecular Biomarkers Product Type
3.6 Tier 1, Tier 2 and Tier 3 Cancer Molecular Biomarkers Players in Global Market
3.6.1 List of Global Tier 1 Cancer Molecular Biomarkers Companies
3.6.2 List of Global Tier 2 and Tier 3 Cancer Molecular Biomarkers Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Cancer Molecular Biomarkers Market Size Markets, 2021 & 2028
4.1.2 Genetic Methods
4.1.3 Protein Methods
4.1.4 Imaging
4.2 By Type - Global Cancer Molecular Biomarkers Revenue & Forecasts
4.2.1 By Type - Global Cancer Molecular Biomarkers Revenue, 2017-2022
4.2.2 By Type - Global Cancer Molecular Biomarkers Revenue, 2023-2028
4.2.3 By Type - Global Cancer Molecular Biomarkers Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Cancer Molecular Biomarkers Market Size, 2021 & 2028
5.1.2 Pharmaceutical
5.1.3 Medical Laboratory
5.1.4 Hospital
5.2 By Application - Global Cancer Molecular Biomarkers Revenue & Forecasts
5.2.1 By Application - Global Cancer Molecular Biomarkers Revenue, 2017-2022
5.2.2 By Application - Global Cancer Molecular Biomarkers Revenue, 2023-2028
5.2.3 By Application - Global Cancer Molecular Biomarkers Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Cancer Molecular Biomarkers Market Size, 2021 & 2028
6.2 By Region - Global Cancer Molecular Biomarkers Revenue & Forecasts
6.2.1 By Region - Global Cancer Molecular Biomarkers Revenue, 2017-2022
6.2.2 By Region - Global Cancer Molecular Biomarkers Revenue, 2023-2028
6.2.3 By Region - Global Cancer Molecular Biomarkers Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Cancer Molecular Biomarkers Revenue, 2017-2028
6.3.2 US Cancer Molecular Biomarkers Market Size, 2017-2028
6.3.3 Canada Cancer Molecular Biomarkers Market Size, 2017-2028
6.3.4 Mexico Cancer Molecular Biomarkers Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Cancer Molecular Biomarkers Revenue, 2017-2028
6.4.2 Germany Cancer Molecular Biomarkers Market Size, 2017-2028
6.4.3 France Cancer Molecular Biomarkers Market Size, 2017-2028
6.4.4 U.K. Cancer Molecular Biomarkers Market Size, 2017-2028
6.4.5 Italy Cancer Molecular Biomarkers Market Size, 2017-2028
6.4.6 Russia Cancer Molecular Biomarkers Market Size, 2017-2028
6.4.7 Nordic Countries Cancer Molecular Biomarkers Market Size, 2017-2028
6.4.8 Benelux Cancer Molecular Biomarkers Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Cancer Molecular Biomarkers Revenue, 2017-2028
6.5.2 China Cancer Molecular Biomarkers Market Size, 2017-2028
6.5.3 Japan Cancer Molecular Biomarkers Market Size, 2017-2028
6.5.4 South Korea Cancer Molecular Biomarkers Market Size, 2017-2028
6.5.5 Southeast Asia Cancer Molecular Biomarkers Market Size, 2017-2028
6.5.6 India Cancer Molecular Biomarkers Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Cancer Molecular Biomarkers Revenue, 2017-2028
6.6.2 Brazil Cancer Molecular Biomarkers Market Size, 2017-2028
6.6.3 Argentina Cancer Molecular Biomarkers Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Cancer Molecular Biomarkers Revenue, 2017-2028
6.7.2 Turkey Cancer Molecular Biomarkers Market Size, 2017-2028
6.7.3 Israel Cancer Molecular Biomarkers Market Size, 2017-2028
6.7.4 Saudi Arabia Cancer Molecular Biomarkers Market Size, 2017-2028
6.7.5 UAE Cancer Molecular Biomarkers Market Size, 2017-2028
7 Players Profiles
7.1 Correlogic Systems
7.1.1 Correlogic Systems Corporate Summary
7.1.2 Correlogic Systems Business Overview
7.1.3 Correlogic Systems Cancer Molecular Biomarkers Major Product Offerings
7.1.4 Correlogic Systems Cancer Molecular Biomarkers Revenue in Global Market (2017-2022)
7.1.5 Correlogic Systems Key News
7.2 AgendiaBv
7.2.1 AgendiaBv Corporate Summary
7.2.2 AgendiaBv Business Overview
7.2.3 AgendiaBv Cancer Molecular Biomarkers Major Product Offerings
7.2.4 AgendiaBv Cancer Molecular Biomarkers Revenue in Global Market (2017-2022)
7.2.5 AgendiaBv Key News
7.3 BioMerieux
7.3.1 BioMerieux Corporate Summary
7.3.2 BioMerieux Business Overview
7.3.3 BioMerieux Cancer Molecular Biomarkers Major Product Offerings
7.3.4 BioMerieux Cancer Molecular Biomarkers Revenue in Global Market (2017-2022)
7.3.5 BioMerieux Key News
7.4 Aureon Laboratories
7.4.1 Aureon Laboratories Corporate Summary
7.4.2 Aureon Laboratories Business Overview
7.4.3 Aureon Laboratories Cancer Molecular Biomarkers Major Product Offerings
7.4.4 Aureon Laboratories Cancer Molecular Biomarkers Revenue in Global Market (2017-2022)
7.4.5 Aureon Laboratories Key News
7.5 Astellas Pharma US
7.5.1 Astellas Pharma US Corporate Summary
7.5.2 Astellas Pharma US Business Overview
7.5.3 Astellas Pharma US Cancer Molecular Biomarkers Major Product Offerings
7.5.4 Astellas Pharma US Cancer Molecular Biomarkers Revenue in Global Market (2017-2022)
7.5.5 Astellas Pharma US Key News
7.6 Becton
7.6.1 Becton Corporate Summary
7.6.2 Becton Business Overview
7.6.3 Becton Cancer Molecular Biomarkers Major Product Offerings
7.6.4 Becton Cancer Molecular Biomarkers Revenue in Global Market (2017-2022)
7.6.5 Becton Key News
7.7 Diadexus
7.7.1 Diadexus Corporate Summary
7.7.2 Diadexus Business Overview
7.7.3 Diadexus Cancer Molecular Biomarkers Major Product Offerings
7.7.4 Diadexus Cancer Molecular Biomarkers Revenue in Global Market (2017-2022)
7.7.5 Diadexus Key News
7.8 Abbott Laboratories
7.8.1 Abbott Laboratories Corporate Summary
7.8.2 Abbott Laboratories Business Overview
7.8.3 Abbott Laboratories Cancer Molecular Biomarkers Major Product Offerings
7.8.4 Abbott Laboratories Cancer Molecular Biomarkers Revenue in Global Market (2017-2022)
7.8.5 Abbott Laboratories Key News
7.9 Affymetrix
7.9.1 Affymetrix Corporate Summary
7.9.2 Affymetrix Business Overview
7.9.3 Affymetrix Cancer Molecular Biomarkers Major Product Offerings
7.9.4 Affymetrix Cancer Molecular Biomarkers Revenue in Global Market (2017-2022)
7.9.5 Affymetrix Key News
7.10 Clarient
7.10.1 Clarient Corporate Summary
7.10.2 Clarient Business Overview
7.10.3 Clarient Cancer Molecular Biomarkers Major Product Offerings
7.10.4 Clarient Cancer Molecular Biomarkers Revenue in Global Market (2017-2022)
7.10.5 Clarient Key News
7.11 Biomoda
7.11.1 Biomoda Corporate Summary
7.11.2 Biomoda Business Overview
7.11.3 Biomoda Cancer Molecular Biomarkers Major Product Offerings
7.11.4 Biomoda Cancer Molecular Biomarkers Revenue in Global Market (2017-2022)
7.11.5 Biomoda Key News
7.12 Beckman Coulter
7.12.1 Beckman Coulter Corporate Summary
7.12.2 Beckman Coulter Business Overview
7.12.3 Beckman Coulter Cancer Molecular Biomarkers Major Product Offerings
7.12.4 Beckman Coulter Cancer Molecular Biomarkers Revenue in Global Market (2017-2022)
7.12.5 Beckman Coulter Key News
7.13 Dickinson
7.13.1 Dickinson Corporate Summary
7.13.2 Dickinson Business Overview
7.13.3 Dickinson Cancer Molecular Biomarkers Major Product Offerings
7.13.4 Dickinson Cancer Molecular Biomarkers Revenue in Global Market (2017-2022)
7.13.5 Dickinson Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Cancer Molecular Biomarkers Market Opportunities & Trends in Global Market
Table 2. Cancer Molecular Biomarkers Market Drivers in Global Market
Table 3. Cancer Molecular Biomarkers Market Restraints in Global Market
Table 4. Key Players of Cancer Molecular Biomarkers in Global Market
Table 5. Top Cancer Molecular Biomarkers Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Cancer Molecular Biomarkers Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Cancer Molecular Biomarkers Revenue Share by Companies, 2017-2022
Table 8. Global Companies Cancer Molecular Biomarkers Product Type
Table 9. List of Global Tier 1 Cancer Molecular Biomarkers Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Cancer Molecular Biomarkers Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Cancer Molecular Biomarkers Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Cancer Molecular Biomarkers Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Cancer Molecular Biomarkers Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application ? Global Cancer Molecular Biomarkers Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Cancer Molecular Biomarkers Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Cancer Molecular Biomarkers Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region ? Global Cancer Molecular Biomarkers Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Cancer Molecular Biomarkers Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Cancer Molecular Biomarkers Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Cancer Molecular Biomarkers Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Cancer Molecular Biomarkers Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Cancer Molecular Biomarkers Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Cancer Molecular Biomarkers Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Cancer Molecular Biomarkers Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Cancer Molecular Biomarkers Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Cancer Molecular Biomarkers Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Cancer Molecular Biomarkers Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Cancer Molecular Biomarkers Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Cancer Molecular Biomarkers Revenue, (US$, Mn), 2023-2028
Table 30. Correlogic Systems Corporate Summary
Table 31. Correlogic Systems Cancer Molecular Biomarkers Product Offerings
Table 32. Correlogic Systems Cancer Molecular Biomarkers Revenue (US$, Mn), (2017-2022)
Table 33. AgendiaBv Corporate Summary
Table 34. AgendiaBv Cancer Molecular Biomarkers Product Offerings
Table 35. AgendiaBv Cancer Molecular Biomarkers Revenue (US$, Mn), (2017-2022)
Table 36. BioMerieux Corporate Summary
Table 37. BioMerieux Cancer Molecular Biomarkers Product Offerings
Table 38. BioMerieux Cancer Molecular Biomarkers Revenue (US$, Mn), (2017-2022)
Table 39. Aureon Laboratories Corporate Summary
Table 40. Aureon Laboratories Cancer Molecular Biomarkers Product Offerings
Table 41. Aureon Laboratories Cancer Molecular Biomarkers Revenue (US$, Mn), (2017-2022)
Table 42. Astellas Pharma US Corporate Summary
Table 43. Astellas Pharma US Cancer Molecular Biomarkers Product Offerings
Table 44. Astellas Pharma US Cancer Molecular Biomarkers Revenue (US$, Mn), (2017-2022)
Table 45. Becton Corporate Summary
Table 46. Becton Cancer Molecular Biomarkers Product Offerings
Table 47. Becton Cancer Molecular Biomarkers Revenue (US$, Mn), (2017-2022)
Table 48. Diadexus Corporate Summary
Table 49. Diadexus Cancer Molecular Biomarkers Product Offerings
Table 50. Diadexus Cancer Molecular Biomarkers Revenue (US$, Mn), (2017-2022)
Table 51. Abbott Laboratories Corporate Summary
Table 52. Abbott Laboratories Cancer Molecular Biomarkers Product Offerings
Table 53. Abbott Laboratories Cancer Molecular Biomarkers Revenue (US$, Mn), (2017-2022)
Table 54. Affymetrix Corporate Summary
Table 55. Affymetrix Cancer Molecular Biomarkers Product Offerings
Table 56. Affymetrix Cancer Molecular Biomarkers Revenue (US$, Mn), (2017-2022)
Table 57. Clarient Corporate Summary
Table 58. Clarient Cancer Molecular Biomarkers Product Offerings
Table 59. Clarient Cancer Molecular Biomarkers Revenue (US$, Mn), (2017-2022)
Table 60. Biomoda Corporate Summary
Table 61. Biomoda Cancer Molecular Biomarkers Product Offerings
Table 62. Biomoda Cancer Molecular Biomarkers Revenue (US$, Mn), (2017-2022)
Table 63. Beckman Coulter Corporate Summary
Table 64. Beckman Coulter Cancer Molecular Biomarkers Product Offerings
Table 65. Beckman Coulter Cancer Molecular Biomarkers Revenue (US$, Mn), (2017-2022)
Table 66. Dickinson Corporate Summary
Table 67. Dickinson Cancer Molecular Biomarkers Product Offerings
Table 68. Dickinson Cancer Molecular Biomarkers Revenue (US$, Mn), (2017-2022)
List of Figures
Figure 1. Cancer Molecular Biomarkers Segment by Type in 2021
Figure 2. Cancer Molecular Biomarkers Segment by Application in 2021
Figure 3. Global Cancer Molecular Biomarkers Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Cancer Molecular Biomarkers Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Cancer Molecular Biomarkers Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Cancer Molecular Biomarkers Revenue in 2021
Figure 8. By Type - Global Cancer Molecular Biomarkers Revenue Market Share, 2017-2028
Figure 9. By Application - Global Cancer Molecular Biomarkers Revenue Market Share, 2017-2028
Figure 10. By Region - Global Cancer Molecular Biomarkers Revenue Market Share, 2017-2028
Figure 11. By Country - North America Cancer Molecular Biomarkers Revenue Market Share, 2017-2028
Figure 12. US Cancer Molecular Biomarkers Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Cancer Molecular Biomarkers Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Cancer Molecular Biomarkers Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Cancer Molecular Biomarkers Revenue Market Share, 2017-2028
Figure 16. Germany Cancer Molecular Biomarkers Revenue, (US$, Mn), 2017-2028
Figure 17. France Cancer Molecular Biomarkers Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Cancer Molecular Biomarkers Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Cancer Molecular Biomarkers Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Cancer Molecular Biomarkers Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Cancer Molecular Biomarkers Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Cancer Molecular Biomarkers Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Cancer Molecular Biomarkers Revenue Market Share, 2017-2028
Figure 24. China Cancer Molecular Biomarkers Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Cancer Molecular Biomarkers Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Cancer Molecular Biomarkers Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Cancer Molecular Biomarkers Revenue, (US$, Mn), 2017-2028
Figure 28. India Cancer Molecular Biomarkers Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Cancer Molecular Biomarkers Revenue Market Share, 2017-2028
Figure 30. Brazil Cancer Molecular Biomarkers Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Cancer Molecular Biomarkers Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Cancer Molecular Biomarkers Revenue Market Share, 2017-2028
Figure 33. Turkey Cancer Molecular Biomarkers Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Cancer Molecular Biomarkers Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Cancer Molecular Biomarkers Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Cancer Molecular Biomarkers Revenue, (US$, Mn), 2017-2028
Figure 37. Correlogic Systems Cancer Molecular Biomarkers Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. AgendiaBv Cancer Molecular Biomarkers Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. BioMerieux Cancer Molecular Biomarkers Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Aureon Laboratories Cancer Molecular Biomarkers Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Astellas Pharma US Cancer Molecular Biomarkers Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Becton Cancer Molecular Biomarkers Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Diadexus Cancer Molecular Biomarkers Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Abbott Laboratories Cancer Molecular Biomarkers Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Affymetrix Cancer Molecular Biomarkers Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Clarient Cancer Molecular Biomarkers Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Biomoda Cancer Molecular Biomarkers Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Beckman Coulter Cancer Molecular Biomarkers Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. Dickinson Cancer Molecular Biomarkers Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
